πŸ‡ΊπŸ‡Έ FDA
Patent

US 11191747

Pyrrole compounds

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 11191747 (Pyrrole compounds) held by Aligos Therapeutics, Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/40, A61K31/4025, A61K31/4192